BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18038545)

  • 21. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK; Strebel PM; de Quadros CA; Olivé JM
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage.
    Korotkova EA; Prostova MA; Gmyl AP; Kozlovskaya LI; Eremeeva TP; Baikova OY; Krasota AY; Morozova NS; Ivanova OE
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32883046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surveillance of acute flaccid paralysis in Belarus].
    Samoĭlovich EO; Ermolovich MA; Kotova IF; Svirchevskaia EIu; Shimanovich VP; Kozhemiakin AK; Protas II; Fel'dman EV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (2):24-31. PubMed ID: 17523475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.
    Kapusinszky B; Molnár Z; Szomor KN; Berencsi G
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis.
    Diamanti E; Ibrahimi B; Tafaj F; Mezini E; Dodbiba A; Dobi V; Catone S; Genovese D; Simeoni P; Fiore L
    Vaccine; 1998; 16(9-10):940-8. PubMed ID: 9682341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain.
    Khalfan SA; Chomel JJ; Mallet L; Fernandes E; Lahlou AI; Lina B; Aymard M
    Ann Trop Paediatr; 2001 Sep; 21(3):223-9. PubMed ID: 11579860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden.
    Platt LR; Estívariz CF; Sutter RW
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S380-9. PubMed ID: 25316859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.
    Strebel PM; Sutter RW; Cochi SL; Biellik RJ; Brink EW; Kew OM; Pallansch MA; Orenstein WA; Hinman AR
    Clin Infect Dis; 1992 Feb; 14(2):568-79. PubMed ID: 1554844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of a Highly Divergent Type 3 Vaccine-Derived Poliovirus in a Child with a Severe Primary Immunodeficiency Disorder - Chongqing, China, 2022.
    Yao N; Liu Y; Xu JW; Wang Q; Yin ZD; Wen N; Yang H; Rodewald LE; Zhang ZY
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(36):1148-1150. PubMed ID: 36074738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
    Kew O; Morris-Glasgow V; Landaverde M; Burns C; Shaw J; Garib Z; André J; Blackman E; Freeman CJ; Jorba J; Sutter R; Tambini G; Venczel L; Pedreira C; Laender F; Shimizu H; Yoneyama T; Miyamura T; van Der Avoort H; Oberste MS; Kilpatrick D; Cochi S; Pallansch M; de Quadros C
    Science; 2002 Apr; 296(5566):356-9. PubMed ID: 11896235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
    Strebel PM; Aubert-Combiescu A; Ion-Nedelcu N; Biberi-Moroeanu S; Combiescu M; Sutter RW; Kew OM; Pallansch MA; Patriarca PA; Cochi SL
    Am J Epidemiol; 1994 Dec; 140(12):1111-24. PubMed ID: 7998593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008.
    Shahmahmoodi S; Mamishi S; Aghamohammadi A; Aghazadeh N; Tabatabaie H; Gooya MM; Zahraei SM; Mousavi T; Yousefi M; Farrokhi K; Mohammadpour M; Ashrafi MR; Nategh R; Parvaneh N
    Emerg Infect Dis; 2010 Jul; 16(7):1133-6. PubMed ID: 20587188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia.
    Tucker AW; Isaacs D; Burgess M
    Aust N Z J Public Health; 2001 Oct; 25(5):411-6. PubMed ID: 11688618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.